Food and Drug Quality Office under the Ministry of Health and Social Services of the United States on November 19 plans to allow booster vaccine vaccinations to the third dose of the COVID-19 of the entire adult population of the country. This is reported by POLITICO edition with reference to sources.
It is noted that this decision will make it possible to make accessible revaccination for millions of Americans, which is especially important on the eve of the winter holidays. The drug from companies Pfizer and Biontech will be used, as well as moderna.
The US administration expressed concern about the increase in the number of cases of infection in the country. Prior to this solution, the booster vaccination of only vulnerable groups of the population was assumed.
Earlier, the Director General of the American company Pfizer Albert Burl stated that the revaccination from coronavirus infection would need to be held approximately every year. He noted that it is necessary to follow the state of people who made a booster vaccination, after the expiration of a six-month period, to understand when they decrease the level of protection, and they will need a new dose of vaccine.